11/2025

• Portfolio News

  Qiming Venture Partners' Portfolio Company WeRide Completes Dual Primary Listing on Hong Kong Stock Exchange

10/2025

• Portfolio News

  Longwood Biopharmaceuticals Secures Hundreds of Millions in Series B+ Financing to Accelerate Core Pipeline Clinical Research and Global Layout

• Portfolio News

  Qiming Venture Partners Exclusively Leads Makera's Pre-A Round

• Portfolio News

  Qiming Venture Partners' Portfolio Company Yunji Technology Successfully Lists on the Hong Kong Stock Exchange

09/2025

• Portfolio News

  Qiming Venture Partners' Portfolio Company Hesai Technology Completes Dual Primary Listing on Hong Kong Stock Exchange

08/2025

• Portfolio News

  Minghui Pharmaceutical Announces USD 131 Million Pre-IPO Financing Co-Led by Qiming Venture Partners

06/2025

• Portfolio News

  Qiming Venture Partners' Portfolio Company Unisound Successfully Lists on the Hong Kong Stock Exchange

04/2025

• Portfolio News

  The Lancet Child & Adolescent Health Publishes Phase 3 Trial and 24-Month Follow-Up Results of Ziresovir for RSV in Infants Under 6 Months

• Portfolio News

  Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved

03/2025

• Portfolio News

  Bloomberg Exclusive Interview with Tony Han, Founder and CEO of WeRide: The Final Winner Will Prevail Through Service Quality

• Portfolio News

  WeRide and Renault Group launch their first autonomous Robobus trial in Spain

• Portfolio News

  Unleashing Swarm Intelligence: UBTECH Pioneers the World's First Multi-Humanoid Robot Collaborative Training in Multi-Task, Multi-Scenario Settings at ZEEKR

• Portfolio News

  CNBC Exclusive Interview with Tony Han, Founder and CEO of WeRide: Autonomous Driving Will "Illuminate" the World Like the Invention of the Light Bulb

• Portfolio News

  Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing Co-led by Qiming Venture Partners 

02/2025

• Portfolio News

  WeRide's Latest Robotaxi GXR to Start First Fully Unmanned Commercial Operations in Beijing

01/2025

• Portfolio News

  Qiming Venture Partners' Portfolio Company HyperStrong Successfully Listed on STAR Market

• Portfolio News

  Iongen Therapeutics Secures Over 100M RMB in Pre-A Financing

12/2024

• Portfolio News

  Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO™ HT Install at Hong Kong Center for Neurodegenerative Diseases

11/2024

• Portfolio News

  MSD Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines

10/2024

• Portfolio News

  The gene therapy for hemophilia B developed by Belief BioMed has received Advanced Therapy Medicinal Product Designation from the EMA

• Portfolio News

  Qiming Venture Partners Celebrates WeRide's IPO on Nasdaq

• Portfolio News

  WeRide Unveils New Production Robotaxi GXR, Leveraging 1,800 Days of Operations

• Portfolio News

  Qiming Venture Partners' Portfolio Company Qiniu Cloud Successfully Lists on HKEX Main Board 

09/2024

• Portfolio News

  Belief BioMed and AskBio, Subsidiary of Bayer, Announced Global Collaboration to Address Unmet Medical Needs with World-Class Gene Therapies

• Portfolio News

  Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI

• Portfolio News

  Hydrogen and hydrogen derivatives-fueled gas turbine company Marvel-Tech completed hundreds of millions of RMB Pre-Series B financing round, led by Qiming Venture Partners

03/2024

• Portfolio News

  Insilico Medicine's Study Published in Nature Biotechnology: First Novel TNIK Inhibitors for Fibrotic Diseases Discovered and Designed Using Generative AI

01/2024

• Portfolio News

  SUPERMAG Raises Over RMB 100 Million in Series A Financing

12/2023

• Portfolio News

  Qiming Venture Partners' Portfolio Company UBTech Listed on Hong Kong Stock Exchange

• Portfolio News

  Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck

11/2023

• Portfolio News

  Clinical Proteomics Startup Complete Omics Inc. Successfully Completes Series A Financing, Exclusively Invested by Qiming Venture Partners

09/2023

• Portfolio News

  Qiming Venture Partners' Portfolio Company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange

08/2023

• Portfolio News

  Epigenic Therapeutics Announces $32M in Series A Funding

05/2023

• Portfolio News

  LTZ Announces over $10 Million Pre-A+ Financing led by Qiming Venture Partners

04/2023

• Portfolio News

  Zai Lab and MediLink Therapeutics Announced Strategic Partnership for a Next Generation Antibody-Drug Conjugate Program in Oncology

• Portfolio News

  Qiming Venture Partners' portfolio company MedSci successfully listed on HKEX main board

• Portfolio News

  Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901

03/2023

• Portfolio News

  Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq

• Portfolio News

  World's First Quadrivalent COVID-19 Vaccine Developed by SinocellTech is Approved for Emergency Use in China

• Portfolio News

  Qiming Venture Partners led two consecutive funding rounds in next-generation precision medicine company Allorion Therapeutics

• Portfolio News

  Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing

• Portfolio News

  TandemAI Raises $35 Million in Series A Financing Led by Qiming Venture Partners

02/2023

• Portfolio News

  Qiming Venture Partners' Portfolio Company LanzaTech Lists on Nasdaq

• Portfolio News

  Qiming Venture Partners Celebrates Hesai Technology's IPO on Nasdaq

• Portfolio News

  Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq

01/2023

• Portfolio News

  China's Leading Adult Interest Learning Service Provider QuantaSing Group Limited Successfully Listed on Nasdaq

12/2022

• Portfolio News

  SinocellTech's Recombinant Protein COVID-19 Vaccine SCTV01C Approved for Emergency Use in China

• Portfolio News

  CanSinoBIO's Convidecia Air™ at a Glance

11/2022

• Portfolio News

  Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion

10/2022

• Portfolio News

  The Case Report of Belief BioMed’s Hemophilia B Gene Therapy Drug Candidate BBM-H901 Published in The New England Journal of Medicine

• Portfolio News

  CANbridge Announced Encouraging Development in Maralixibat in Rare Liver Disease

• Portfolio News

  WeRide and Hyundai Plan to Fuel Self-driving with Hydrogen in China

• Portfolio News

  OriCell's GPRC5D CAR-T Received Orphan Drug Designation from FDA

• Portfolio News

  CanSinoBIO Celebrates the Rollout of Inhaled Vaccine Convidecia Air™ in Shanghai

• Portfolio News

  Abbisko Obtained Phase III Clinical Trial Approval for ABSK021 from CDE of NMPA

• Portfolio News

  TigerGraph Announced Commitment to Support openCypher in GSQL

• Portfolio News

  Qiming Venture Partners' portfolio Transwarp successfully lists on STAR Market

• Portfolio News

  CANbridge in Oral Presentation at ESGCT 29th Annual Congress

• Portfolio News

  AmoyDx and BeiGene Announced Strategic Cooperation on HER2 Companion Diagnostics

• Portfolio News

  Jacobio Pharma Announced a Clinical Trial Collaboration Agreement with Merck